San Diego Business Journal

Massachusetts Imposes New Restrictions on Zohydro

The saga continues for San Diego’s embattled Zogenix Inc., as it continues to voice objection to the new restrictions placed by the state of Massachusetts on the sale of its narcotic painkiller, Zohydro.

Tease photo

Q3 Earnings Are Up at ResMed Inc.

Earnings for ResMed Inc. continue to rise, with a net income of $90 million for the quarter ended March 31 as compared with $84.9 from the previous year.

Tease photo

Illumina’s Q1 Revenue Is Up 27%

Revenue for Illumina Inc. surged in the first quarter of 2014, thanks to the “astonishing demand” for a slew of newly released gene sequencing products, said CEO Jay Flatley.

$6.5M Donation to UCSD Will Fund Eye Research Lab

grateful patient has gifted University of California, San Diego $6.5 million to establish the Richard C. Atkinson Laboratory for Regenerative Ophthalmology at the university’s Shiley Eye Center.

$6.5M Gift to UCSD Will Go Toward Eye Research Lab

A grateful patient has gifted University of California, San Diego $6.5 million to establish the Richard C. Atkinson Laboratory for Regenerative Ophthalmology at the university’s Shiley Eye Center.

Scripps Advance to Fill Need for Speed in Pharma

BIOTECH: Goal Is to Quickly Get Research To Development Phase

The Scripps Research Institute has formed a new drug discovery company called Scripps Advance to fast-track the translation of early-stage biomedical research into clinical development and, ultimately, commercialization.

Life Sciences See Stock Spotlight Dim as Challenges Take Focus

Biotech: Ups and Downs A Common Reality Among Industry’s Local Public Cos.

Public companies in San Diego’s biotech industry have been on quite the roller coaster, a trend reflected in how that sector is represented in the San Diego Business Journal’s new list of the 50 largest local public companies, ranked by revenue in fiscal 2013.

Covered California Reports 1.4M Enrolled

HEALTH: Signups Surge at End; 88% Eligible for Subsidies

The final surge of Covered California signups ended April 15 with more than 1.4 million enrolled, vastly exceeding initial estimates, despite some confusion in the signup process. However, the number of small businesses enrolled in the exchange’s Small Business Health Options Program, or SHOP, was much lower — about 1,150 signed up, representing about 4,900 employees and their dependents.

Vital Therapies Launches IPO

Vital Therapies Inc. has hit the public markets, but has priced its stock below the expected range, raising gross proceeds of $54 million by offering 4.5 million shares at $12 apiece.

Zogenix Obtains Preliminary Injunction Against Massachusetts’ Ban of Painkiller

Zogenix Inc., the San Diego drugmaker embroiled in controversy over its new opioid painkiller Zohydro ER, finally has a win under its belt — it has successfully blocked an order from Massachusetts Governor Deval Patrick to ban the drug in that state.

BIO's Launches New System to Promote Cos. Connecting at June Convention

The Biotechnology Industry Organization, shortened to BIO, has launched its one-on-one partnering system that will help companies initiate private meetings and gain business contacts at its annual convention, which will be held this June in San Diego.

BIO Launches System to Connect Companies at June Convention

The Biotechnology Industry Organization, shortened to BIO, has launched its one-on-one partnering system that will help companies initiate private meetings and gain business contacts at its annual convention, which will be held this June in San Diego.

Senomyx’s Stock Gets a Boost from New Deal With PepsiCo

Stock for San Diego flavor maker Senomyx Inc. rose after signing a new deal with PepsiCo Inc. to develop chemicals that will “restore the desired salty taste in products with reduced salt.”

Incubator Gains Momentum, ‘Rock Stars’ Through Its Successes

Biotech: Janssen Labs Is Selective, Not Controlling Of Its Life Science Startups

A Torrey Pines-based life sciences incubator that began two years ago as an “experiment” by pharmaceutical and consumer product giant Johnson & Johnson has today shown more momentum than anyone back then would have imagined.

Genomatica Part of Biorenewables Pivot

Biotech: Lack of Market For Biofuels Spurs Flexibility

Biofuels don’t hold the same cachet or glamour they once had, but companies like San Diego’s Genomatica Inc. are showing that the market opportunity is still there for biorenewable products. In particular, specialty chemicals and nutritional supplements are proving to be economically viable industries in the sustainability space.

Tech and Biotech Stocks Slump

Biotech and tech stocks have been in a slump for the past three weeks, evidenced in part by the 3.1 percent drop in the Nasdaq Composite — the worst one day percentage decline, according to MarketWatch, since November 2011.

Tease photo

New PepsiCo Deal Boosts Senomyx Inc.’s Stock

Stock for San Diego flavor maker Senomyx Inc. rose after the company signed a new deal with PepsiCo to develop chemicals that will “restore the desired salty taste in products with reduced salt.”

Tease photo

Palomar Health Facing Possible $250,000 Fine for Data Breach

The California Department of Public Health could fine Palomar Health up to $250,000 in connection with the theft of flash drives containing patient data.

Lumena Files for $75 Million IPO

Lumena Pharmaceuticals Inc. has filed for a $75 million initial public offering, just a few weeks after it closed a $45 million Series B financing round.

Tease photo

Zogenix Getting a Heaping Dose of Criticism for Zohydro

PHARMA: Stock Takes Hit, But Co. Defends Painkiller

Zogenix Inc. is in damage control mode as it faces a maelstrom of criticism for its newly launched narcotic painkiller.

Fund Aims to Connect S.D. Biotech to China

Venture Capital: China’s Money, Manufacturing are Key

Lauded San Diego philanthropist Malin Burnham has teamed with Tom Gephart, an old-school venture capitalist, to launch a $200 million “Cross-Border Innovation Fund,” aiming to finance 10 to 20 startups with money largely from China.

Tease photo

Sorrento Therapeutics Creates Subsidiary to Focus on Animal Treatments

Sorrento Therapeutics Inc. (Nasdaq: SRNE), a maker of cancer and pain medications, has launched a new subsidiary called Ark Animal Therapeutics.

Medical Marijuana Inc. Relocates to Poway Complex

Medical Marijuana Inc., having outgrown its San Diego headquarters, is relocating to a multibuilding campus in Poway.

Tease photo

ATyr Pharma Inc. Appoints New CMO and a Director

ATyr Pharma Inc., a company that treats diseases of the immune system, has appointed biotech veteran David Weiner as its chief medical officer.

Tease photo

Barnes Leaving San Diego Post for a New Role With Kaiser

Mary Ann Barnes, executive director of Kaiser Permanente San Diego, is taking a new role at the health system – she’s been named regional president of Kaiser Permanente Hawaii Region.

Tease photo

Mary Ann Barnes Leaving San Diego Post for New Role With Kaiser

Mary Ann Barnes, executive director of Kaiser Permanente San Diego, is headed to the tropics to take on a new role at the health system – she’s been named regional president of Kaiser Permanente Hawaii Region.

La Jolla Biotech Company Targets China for Arthritis Drug Trials

RuiYi Inc., a biotechnology company split between La Jolla and Shanghai, has received $15 million in Series B financing from existing investors to further its uncommon business model.

Tease photo

New Drug ‘Pipeline’ Runs Under the Sea

BIOTECH: Sirenas Exploring Oceans to Find Possible Cures

Sirenas Marine Discovery Inc. is in an enviable position — it’s actually turning away investors as it turns to the ocean’s depths as a promising source for potential new drugs.

$1.4 Billion Settlement Proposed for San Onofre Closure

Southern California utility customers could see returns of $1.4 billion if a joint settlement related to last year’s shuttering of the San Onofre nuclear plant is approved.

Gary and Mary West Health Investment Fund Announces Sale of Sense4Baby Inc.'s Assets

The Gary and Mary West Health Investment Fund made a series of announcements – most notably that the assets of Sense4Baby Inc., its smartphone-based pregnancy monitoring company, have been acquired by San Antonio’s AirStrip Technologies LP.

RuiYi Receives $15M in Funding

RuiYi Inc., a biotech based both in La Jolla and Shanghai, has received $15 million in Series B financing from a group of existing investors.

Assay Depot Receives $3M in Series B Funding

Assay Depot Inc., Carlsbad’s self-dubbed “Amazon.com for scientists,” has landed $3 million in Series B funding.

SeniorQuote Insurance Services Completes $1.4M Funding Round

San Diego-based SeniorQuote Insurance Services Inc. has completed a $1.4 million Series A round.

Seragon Pharmaceuticals Names Former Onyx Pharmaceuticals CEO to its Board

Newly formed Seragon Pharmaceuticals Inc. has appointed N. Anthony Coles, the former CEO and board chairman of Onyx Pharmaceuticals Inc., to its board of directors.

Tease photo

Construction Complete on New UCSD Biomedical Research Facility

Construction is complete for the new, $113 million University of California, San Diego Health Sciences Biomedical Research Facility.

Construction Complete on UCSD Biomedical Research Facility

Construction is complete for the new, $113 million University of California, San Diego Health Sciences Biomedical Research Facility.

Congress Members, Researchers Push for More NIH Funding

U.S. Reps. Susan Davis and Scott Peters, both Democrats from San Diego, gathered with a group of the region’s medical research stakeholders to solicit Congress to increase funding for the National Institutes of Health, which funds much of the medical research taking place in this area.

Coalition Seeks to Curb Problem of Drug Theft at Open Houses

A coalition of businesses, nonprofits and San Diego real estate professionals has banded together to prevent prescription drug theft at open houses. Key to the group’s mission is ensuring the safe use, storage and disposal of prescription drugs.

Anaptys Lands Lucrative Development Deal

BIOTECH: Tesaro Will Develop 3 of Co.’s Drugs

AnaptysBio Inc., a player in the hot field of cancer immunotherapy, has attracted $17 million up front in a drug development rights deal with Massachusetts-based Tesaro Inc. that could ultimately be worth hundreds of millions more.

New Life Sciences Co. Ready to Buy Others

BIOTECH: No Narrow Niches For Maravai and Local CEO

Chicago private equity firm GTCR is doling out up to $300 million to launch Maravai Life Sciences Inc. in San Diego, tapping the expertise of former Gen-Probe Inc. executives Carl Hull and Eric Tardif to lead a new, acquisition-driven venture.

Richard Branson to Be Keynote Speaker at Biotech Convention Set for San Diego

Billionaire Virgin Group founder Richard Branson will be the keynote speaker at the 2014 Bio International Convention in San Diego — one of the nation’s largest biotechnology forums that attracts more than 15,000 attendees each year.

Tease photo

AMN Healthcare Investing in Telepharmacy Company

San Diego staffing firm AMN Healthcare Services Inc. will invest $5 million in a series of staged payments to San Francisco telepharmacy company PipelineRx.

Tease photo

Mallinckrodt Completes Acquisition of Cadence Pharmaceuticals

Irish specialty drugmaker Mallinckrodt PLC has completed the $1.4 billion purchase of San Diego-based Cadence Pharmaceuticals Inc. The deal was announced initially in February.

New Private Equity-Backed Company Ready to Acquire Life Sciences Firms

Former Gen-Probe executives Carl Hull and Eric Tardif have been tasked by a Chicago-based private equity firm to launch a life sciences company in San Diego aimed at acquiring other companies and with a few hundred million dollars at the ready.

Tease photo

U.S. Reps from San Diego Urge Increase in NIH Funding

U.S. Reps. Susan Davis and Scott Peters, both Democrats from San Diego, gathered with a group of the region’s medical research stakeholders to solicit Congress to increase funding for the National Institutes of Health, which funds much of the medical research taking place in this area.

Tease photo

New Kaiser Medical Office Building to Open

Kaiser Permanente will open a new medical office building in Oceanside on March 17.

AnaptysBio Inc. Partnership Deal Could Be Worth $125M

AnaptysBio Inc. could receive up to $125 million from a new partnership with Massachusetts cancer drugmaker Tesaro Inc., including $17 million upfront

AnaptysBio Inc. Deal Could Be Worth $125 Million

AnaptysBio Inc. could receive up to $125 million from a new partnership with Massachusetts cancer drugmaker Tesaro Inc., including $17 million upfront.

Zogenix’s Powerful Painkiller Faces Attacks From Two Fronts

Things aren’t looking great for Zogenix Inc. nor its flagship drug, the powerful narcotic painkiller Zohydro. The company’s stock recently plummeted on news that a competitor just might have built a better mousetrap — drug — and could soon emerge on the market.

Tease photo

Experience With Illness Is Catalyst for Creating New Business

BIOTECH: Proactive Patient Got to Work on New Mobility Device

Extreme athlete Kim Goodsell has a bevy of health conditions that could severely limit her ability to walk. But with research, ingenuity and sheer pluck she has taken charge of her own health — and launched a new company as a result.

Prev